X4 Pharmaceuticals, Inc.【XFOR】 利益剰余金の推移

機能の使い方
(単位:千ドル) 利益剰余金 前年比(%)
1Q25 -515,100 -2.8%
4Q24 -515,400 +7.8%
3Q24 -475,500 +3.6%
2Q24 -438,800 -3.9%
1Q24 -529,700 +32.2%
4Q23 -477,900 +26.9%
3Q23 -458,800 +32.0%
3Q23 -456,500 +40.0%
3Q23 -400,800 +31.5%
4Q22 -376,738 +33.2%
3Q22 -347,634 +37.6%
2Q22 -326,048 +40.2%
1Q22 -304,836 +43.2%
4Q21 -282,900 +45.7%
3Q21 -252,664 +43.7%
2Q21 -232,489 +46.9%
1Q21 -212,851 +48.6%
4Q20 -194,200 +47.1%
3Q20 -175,800 +45.0%
2Q20 -158,300 +53.0%
1Q20 -143,200 +58.9%
4Q19 -132,044 -2.4%
3Q19 -121,207 -3.7%
2Q19 -103,493 -10.0%
1Q19 -90,110 -12.4%
4Q18 -135,286 -
3Q18 -125,928 -
2Q18 -115,028 -
1Q18 -102,895 -